Gamma Medical to Show Enhanced MBI System

Article

Gamma Medica will debut at RSNA 2013 upgrades to its LumaGEM molecular breast imaging system, the company announced.

The system will have a redesigned collimator increasing sensitivity by 20 percent, which will accelerate image acquisition and decrease procedural time, the company said. The company will also introduce an improved breast compression system designed to improve patient stability.

Gamma Medica’s LumaGEM detects tumors as small as 5 mm in mammographically dense and other difficult-to-image breast tissue. The technology can visualize tumors surrounded by non-cancerous glandular tissue, the company said, and may be better than mammography for imaging women with difficult-to-detect lobular tumors, scar tissue from previous surgeries, implants and small distant metastases.

 

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Related Content
© 2025 MJH Life Sciences

All rights reserved.